Reykjavik, Iceland-based deCODE Genetics Inc. is publicly traded and has a market capitalization of about $100 million (€63 million). It recently began offering its own personal genomic scanning service, deCODEme, which analyzes about 1 million genetic variations for just under $1,000 (€632).
"I am convinced that within five years every college-educated person in America is going to have a profile like this," said deCODE chief executive Kari Stefansson. "You cannot afford not having this."
Given deCODE's rapidly dwindling financial reserves, I suspect it's more that he can't afford you not having it...
1 comments:
Great post....
LOL
-Steve
www.thegenesherpa.blogspot.com
Post a Comment